Stock Events
Stock Events
Search...
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Ligand Pharmaceuticals (LGND) Q2 2018 Earnings
LGND
8
May
Confirmed
Q3 2017
Q4 2017
Q1 2018
Q2 2018
0.47
0.83
1.19
1.55
Details
Expected EPS
1.28
Actual EPS
1.55
Surprise EPS
0.27
Surprise Percent
+21.09%
Description
Ligand Pharmaceuticals (LGND) has reported earnings of 1.55 per share for Q2 2018.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist